THANK YOU FOR SUBSCRIBING
Connecticut Biotech began production and sales of the product in July but in limited quantities. Currently, the company is refining and improving its process with plans for vastly scaled-up production and distribution capacity by late 2020.
FREMONT, CA: A new innovative startup company, Connecticut Biotech, announced the launch of its Secure Fit 3D printed mask frame. The mask creates an exoskeleton that can be worn outside a traditional surgical mask, which will provide enhanced efficacy in protection against COVID-19 and other airborne pathogens. Secure Fit can be reused and is a reliable device designed to make day-to-day interactions safer for users.
"Our Secure Fit mask frames increase the efficacy of masks and provide more protection because it is custom-made for each user," said CEO of Connecticut Biotech Don Vaccaro. "This not only ensures a comfortable fit, but a more secure fit." Connecticut Biotech developed the technology under the leadership of Dr. Cato T. Laurencin and in partnership with the University of Connecticut. The mask frame will help cloth, and disposable surgical masks fit tighter to the face.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
"This is an important technology that can help a lot of people by providing a specific way to make regular surgical masks more protective," says Dr. Laurencin. "It's wonderful to see technology that started here in the state of Connecticut being developed by a local company." Connecticut Biotech began production and sales of the product in July but in limited quantities. Currently, the company is refining and improving its process with plans for vastly scaled-up production and distribution capacity by late 2020.
The concept of using facial-recognition software to pinpoint 3D-printing specifications for custom fitting was developed by UConn Health's Dr. Cato T. Laurencin and his team of researchers at the Connecticut Convergence Institute for Translation in Regenerative Engineering. The continued support from UConn's Technology Commercialization Services, aided Dr. Laurencin and his researchers submitted a patent application for the process earlier this year.
More in News